PEMETREXED IN COMBINATION WITH ERLOTINIB AS A SALVAGE TREATMENT IN PATIENTS WITH METASTATIC BILIARY TRACT CANCER (BTC) WHO FAILED GEMCITABINE CONTAINING CHEMOTHERAPY: A PHASE II SINGLE ARM PROSPECTIVE STUDY: